Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) EBIT Margin Growth (3y) (2012 - 2026)

Analysis

Revvity (RVTY) EBIT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 263.00
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -168.00
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 1,569.00
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 2,862.00
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 123.00
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -825.00
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -201.00
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -527.00
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 3,021.00
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -2,043.00
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 123.00
Apr 5, 2026 -61.00
Dec 28, 2025 -407.00
Sep 28, 2025 -385.00
Jun 29, 2025 -1,336.00
Mar 30, 2025 -1,633.00
Dec 29, 2024 -1,289.00
Sep 29, 2024 -836.00
Jun 30, 2024 -2,142.00
Mar 31, 2024 -3,748.00
Oct 1, 2023 -1,540.00
Jul 2, 2023 -1,063.00
Apr 2, 2023 443.00
Jan 1, 2023 138.00
Oct 2, 2022 444.00
Jul 3, 2022 1,326.00
Apr 3, 2022 1,898.00
Jan 2, 2022 1,388.00
Oct 3, 2021 1,081.00
Jul 4, 2021 2,130.00